top of page
There are many unanswered questions that need to be addressed in order to achieve better control and prevention of illness due to arbovirus infection. These problems range from assessing baseline population immunity, conducting effective surveillance for introductory or epidemic transmission events, to assessing efficacy of interventions designed to reduce arbovirus transmission. We leverage our capacity in arbovirus serology to collaborate with colleagues and partners who share mutual research goals that are ultimately related to reducing arbovirus infections globally.
DOES DENGUE IMMUNITY AFFECT BIRTH OUTCOMES FOLLOWING MATERNAL ZIKA INFECTION?
DO NOVEL VECTOR CONTROL INTERVENTIONS REDUCE TRANSMISSION OF AEDES-BORNE VIRUSES?
IS DENGUE A CAUSE OF NON-MALARIAL ACUTE FEBRILE ILLNESS IN UGANDA?
WHAT IS THE IMMUNOLOGIC LANDSCAPE FOR ARBOVIRUSES AMONG PREGNANT WOMEN IN RISARALDA, COLOMBIA?
bottom of page